EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Rational design and virtual screening identify mimetics of the RXR agonist valerenic acid

Laura Isigkeit, Annette Kärcher, Gustave Adouvi, Silvia Arifi, Daniel Merk iD

ChemMedChem · 2024

DOI: 10.1002/cmdc.202300379 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, 2024. Verfasst von Laura Isigkeit und 4 weiteren Autor:innen. Beteiligte Einrichtung: Goethe University Frankfurt, Institute of Pharmaceutical Chemistry, 60438, Frankfurt, Germany. Hauptthemen laut MEDLINE: Indenes, Sesquiterpenes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Research Foundation, Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The ligand‐sensing transcription factor retinoid X receptor (RXR) is the universal heterodimer partner of nuclear receptors and involved in multiple physiological processes. Its pharmacological modulation holds therapeutic potential in cancer and neurodegeneration but many available RXR ligands lack specificity. The sesquiterpenoid valerenic acid has been identified as RXR agonist with unprecedented subtype and homodimer preference. Here, we identified simplified mimetics of the complex natural product by rational design and virtual screening that exhibited similar activity profiles on RXR and informed about structural elements contributing to the favorable activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IndenesSesquiterpenesRetinoid X ReceptorsReceptors, Retinoic Acid

Stichwörter der Autor:innen

natural product mimeticretinoid X receptortranscription factor

Substanzen

Retinoid X ReceptorsReceptors, Retinoic Acidvalerenic acidIndenesSesquiterpenes

Autor:innen und Institutionen

  • Goethe University Frankfurt, Institute of Pharmaceutical Chemistry, 60438, Frankfurt, Germany.
  • Ludwig-Maximilians-Universität München, Department of Pharmacy, 81377, Munich, Germany.

ORCID-Profile: Daniel Merk

Förderung

  • German Research Foundation
  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Isigkeit, L., Kärcher, A., Adouvi, G., Arifi, S., & Merk, D. (2024). Rational design and virtual screening identify mimetics of the RXR agonist valerenic acid. ChemMedChem. https://doi.org/10.1002/cmdc.202300379

Vancouver

Isigkeit L, Kärcher A, Adouvi G, Arifi S, Merk D. Rational design and virtual screening identify mimetics of the RXR agonist valerenic acid. ChemMedChem. 2024. doi:10.1002/cmdc.202300379

BibTeX
@article{Isigkeit2024,
  author = {Isigkeit, Laura and Kärcher, Annette and Adouvi, Gustave and Arifi, Silvia and Merk, Daniel},
  title = {Rational design and virtual screening identify mimetics of the RXR agonist valerenic acid},
  journal = {ChemMedChem},
  year = {2024},
  doi = {10.1002/cmdc.202300379}
}
Kostenlos starten →